Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,224 | 1,241 | 99.4% |
| Education | $131.26 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,970 | 161 | $0 (2024) |
| PFIZER INC. | $1,326 | 96 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,319 | 82 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,228 | 86 | $0 (2024) |
| Astellas Pharma US Inc | $1,089 | 53 | $0 (2023) |
| Amgen Inc. | $884.17 | 49 | $0 (2024) |
| Merck Sharp & Dohme LLC | $881.18 | 67 | $0 (2024) |
| Lilly USA, LLC | $684.56 | 57 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $655.50 | 63 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $654.32 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,246 | 121 | Neurocrine Biosciences, Inc. ($267.95) |
| 2023 | $2,532 | 139 | PFIZER INC. ($271.41) |
| 2022 | $2,776 | 158 | Novo Nordisk Inc ($510.59) |
| 2021 | $2,728 | 155 | Novo Nordisk Inc ($619.90) |
| 2020 | $2,136 | 142 | Novo Nordisk Inc ($535.00) |
| 2019 | $2,256 | 157 | Astellas Pharma US Inc ($316.62) |
| 2018 | $2,855 | 183 | PFIZER INC. ($316.66) |
| 2017 | $2,825 | 192 | Novo Nordisk Inc ($424.15) |
All Payment Transactions
1,247 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $35.85 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Endocrinology | ||||||
| 11/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $37.64 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $92.60 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $19.22 | General |
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 4,233 | 6,607 | $698,831 | $236,531 |
| 2022 | 40 | 4,844 | 7,460 | $627,318 | $268,812 |
| 2021 | 37 | 4,318 | 6,872 | $580,441 | $249,682 |
| 2020 | 38 | 4,982 | 7,057 | $556,450 | $201,455 |
All Medicare Procedures & Services
167 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 727 | $159,270 | $56,513 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 219 | 219 | $28,470 | $26,194 | 92.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 201 | 362 | $29,765 | $15,520 | 52.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 203 | 241 | $23,502 | $14,861 | 63.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 119 | 157 | $18,459 | $12,435 | 67.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 192 | $27,900 | $11,075 | 39.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 108 | 110 | $16,255 | $11,057 | 68.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 134 | 187 | $15,330 | $10,409 | 67.9% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 137 | 176 | $16,209 | $10,044 | 62.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 66 | 67 | $13,437 | $9,045 | 67.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 97 | 127 | $14,606 | $7,538 | 51.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 251 | 414 | $65,064 | $5,322 | 8.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 31 | $10,215 | $4,611 | 45.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 261 | 447 | $53,363 | $4,570 | 8.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 273 | 556 | $16,680 | $4,566 | 27.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 19 | $7,250 | $3,958 | 54.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 218 | 218 | $6,047 | $3,664 | 60.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 197 | 345 | $37,278 | $3,240 | 8.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 260 | 425 | $28,851 | $3,170 | 11.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 27 | 27 | $3,983 | $2,695 | 67.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 101 | 101 | $2,020 | $1,712 | 84.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 32 | 41 | $4,100 | $1,353 | 33.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 36 | 42 | $6,489 | $1,218 | 18.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 57 | 73 | $9,614 | $1,202 | 12.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 59 | 59 | $9,093 | $1,116 | 12.3% |
About Dr. Michael Satchell, MD
Dr. Michael Satchell, MD is a Family Medicine healthcare provider based in Albany, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205822806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Satchell, MD has received a total of $20,355 in payments from pharmaceutical and medical device companies, with $2,246 received in 2024. These payments were reported across 1,247 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($20,224).
As a Medicare-enrolled provider, Satchell has provided services to 18,377 Medicare beneficiaries, totaling 27,996 services with total Medicare billing of $956,480. Data is available for 4 years (2020–2023), covering 167 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Albany, GA
- Active Since 09/20/2005
- Last Updated 07/17/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205822806
Products in Payments
- Ozempic (Drug) $1,411
- TRELEGY ELLIPTA (Drug) $1,090
- ELIQUIS (Drug) $934.67
- FARXIGA (Drug) $839.05
- Kerendia (Drug) $654.32
- MYRBETRIQ (Drug) $560.30
- JARDIANCE (Drug) $556.68
- XARELTO (Drug) $535.45
- NUPLAZID (Drug) $456.39
- Dexcom G6 Transmitter (Medical Supply) $423.90
- ENTRESTO (Drug) $397.21
- JANUVIA (Drug) $389.16
- INGREZZA (Drug) $387.92
- Rybelsus (Drug) $332.78
- TRULICITY (Drug) $309.59
- Livalo (Drug) $304.95
- Otezla (Drug) $282.45
- Aimovig (Biological) $272.20
- Saxenda (Drug) $271.35
- BELSOMRA (Drug) $271.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Albany
Daniel Arenos, M.d, M.D
Family Medicine — Payments: $26,134
Bruce Houston, D.o, D.O
Family Medicine — Payments: $23,151
Theodore Hausler, D.o, D.O
Family Medicine — Payments: $16,979
Stephanie Williams, M.d, M.D
Family Medicine — Payments: $16,489
Mr. Derek Heard, Md, MD
Family Medicine — Payments: $15,696
Dr. Latifat Agbeja, M.d, M.D
Family Medicine — Payments: $14,194